• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    28 Jan 2022
    Five interesting stocks today

    Five interesting stocks today

    • Cipla: This pharmaceutical company’s results were a mixed bag in Q3FY22. Although its net profits were down by 2.6% YoY to Rs 728.6 crore, but revenues grew 6% YoY to Rs 5,478.9 crore. Domestic revenues were up 12.9% YoY, while US revenues rose 8.8% YoY to Rs 1,124 crore. Growth in US markets was driven by an increase in demand for Cipla’s core products and those in its respiratory portfolio. Revenues from the South African private market also grew 16% YoY to US $60 million.

    The company’s ingredients (API) segment’s revenues fell 25% YoY (US $20 million), which pulled its quarterly revenues down. EBITDA margins fell 135 bps YoY to 22.5%, which pulled down profits. Brokerages like HDFC Securities and ICICI Securities are still upbeat about this company’s prospects and upgraded their target price for the stock by nearly 23% to Rs 1,115 and Rs 1,100, respectively, as they see robust growth opportunities in Indian and US markets. The company’s plans to shift focus from loss-making segments like HIV drugs to more profit-making segments like respiratory and core products as these would be the key drivers for growth in FY23. The US market is likely to gain more momentum in terms of revenue growth once the approvals for drugs like gRevlimid, gAdvair, gAbraxane, and Albuterol’s portfolio of drugs come in from the US FDA and they start earning Cipla revenues.

    • Lux Industries: This stock slumped on Tuesday and tanked 20% after the markets regulator SEBI held Executive Director Udit Todi guilty of insider trading.  Udit Todi is Managing Director Pradip Kumar Todi’s son. SEBI banned 14 entities for insider trading and ordered impounding of wrongful gains of Rs 2.94 crore. SEBI held that Udit Todi leaked sensitive information about the company’s financials to Avni Todi and Sanjeev Bubna, Udit Todi’s father-in-law. Then the related parties bought shares of the company from May 21, 2021, till right before the earnings were announced on May 25, 2021.

    When the stock surged 40% in just three days after the results were announced, the related parties sold off a considerable number of shares and earned substantial profits out of it,  SEBI held in its order. The regulator SEBI has scrutinized the deals on receiving an alert of abnormal trading being carried out. Its preliminary examination gave out detailed information of the insider trading been carried out by Udit Todi, during the UPSI (Unpublished Price Sensitive Information) period and reveals the existence of close connections among the participatory entities. For now, SEBI has banned all the entities from trading into the securities market till the investigation is completed. The company denied this and so did Udit Todi. The company is in the process of seeking clarification for the same, as dictated by SEBI norms. 

    • APL Apollo Tubes: The stock of this market leader in the structural steel tubes industry corrected nearly 24% from its 52-week high on December 16, 2021. The company’s Q3FY22 net profit fell 12.4% YoY to Rs 115.6 crore despite revenue rising 24.2% YoY to Rs 3,238.3 crore. Sales volumes in Q3 fell 17% YoY to 4.02 lakh tonne due to an extended monsoon season, weak construction activity and its distributors reducing stocks in anticipation of a fall in steel prices. Interestingly, realisations jumped over 50% YoY to Rs 77,569/tonne, which aided the top line growth.

    However, this didn’t completely cushion the impact of higher input costs (up over 30% YoY) which in turn hit profits. Brokerages like HDFC Securities, ICICI Securities,and Motilal Oswal continue to be upbeat on the company’s prospects. This is primarily on account of the company’s medium-term plan to double its sales volumes to four million tonnes per annum by FY25 and maintain its EBITDA/tonne at Rs 5,000 levels. Notably, the management does not see a further correction in steel prices as a detriment to its profitability. Infact, it believes that lower HRC prices make it more competitive vis-à-vis traditional construction materials. With two back-to-back quarters of falling net profits and sales volumes, APL Apollo’s Q4FY22 performance could be an interesting inflection point to watch out for investors.

    • Shoppers Stop: On January 21, this departmental store chain’s stock hit a 52-week high on the bourses after its bottomline returned to black for the first time in 11 quarters. The stock is up nearly 7.6% in the past week. Investors must be wondering whether this trend in profitability is sustainable or will Omicron ruin this party yet again. Consolidated net profit was Rs 77.3 crore in Q3FY22 as against a loss of Rs 25.1 crore a year ago. Revenues  rose 34% YoY to Rs 972.6 crore led by a robust festive period and marriage season during October-November 2021. Customer footfalls rose 65% YoY to 1.09 crore and average transaction by 13% YoY to Rs 4,345. If we further dissect the revenue growth segment-wise, beauty and private brands were the primary growth drivers in Q3. The sales from the beauty segment and private brands were up 40% and 31% YoY, respectively.

    The focus of the new Managing Director Venu Nair is to steadily increase the share of high-margin private brands in the overall sales mix. Sales from the digital channels jumped 39% YoY to Rs 70 crore. While ICICI Securities is positive on the medium-term prospects of the company given its aim to double its sales by FY25, Motilal Oswal is cautious. This is because the brokerage feels the company’s past performance isn’t much to write home about. In the past five years, the company witnessed a sustained fall in the same-store sales growth (SSSG) and closure of non-performing stores. Only time will tell if the new management can sustain the current quarters’ performance over FY22-23 and achieve its target SSSG growth of 9-11% in the near term.

    • Sharda Cropchem: This agrochemicals company’s stock is on fire after it announced its Q3FY22 results that saw its consolidated net profitmore than double to Rs 102.2 crore on a 1.8X rise in revenues to nearly Rs 880 crore. The company announced its results on Saturday, and when trade opened after the weekend on Monday, the stock was up 17% and touched a 52-week high. Then on Thursday, breached this 52-week high and touched a lifetime high of Rs 577.85. This upmove made the company’s stock the most overbought among the Nifty 500 companies according to technical indicators like MFI and RSI.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    25 Jan 2022
    Chart of the Week: Airlines’ passenger load factor rises 10 percentage points YoY in Q3FY22

    Chart of the Week: Airlines’ passenger load factor rises 10 percentage points YoY in Q3FY22

    By Deeksha Janiani

    Although passenger traffic is up 33% YoY and airlines carried nearly 8.35 crore passengers in 2021, the 2019 level of 14.4 crore passengers is so far, out of reach. This was especially due to weak demand from the corporate traveler segment. Domestic air passenger traffic rose over 2X on a YoY basis in Q3FY22 to 3.03 crore, thanks to low Covid 19 infections and holiday travel. The festival rush made headlines - the media reported serpentine airport queues, missed flights, and arguments over people trying to skip the line.

    The rise in passenger traffic by 1.08 crore in Q3FY22 had a positive impact on the passenger load factor (PLF) of major airlines. PLF measures the capacity utilization of an airline. The average PLF for the top five airlines rose to 79.5% for Q3FY22, up 10 percentage points from 69.6% in Q3FY21. Market leader InterGlobe Aviation (Indigo) flew 63 lakh more passengers in Q3FY22 and improved its PLF by 8.3 percentage points. Surprisingly, Air India’s average PLF in Q3FY22 jumped 12.5 percentage points YoY, the highest amongst the other top airlines.

    Go First not only improved its average PLF by 11.2 percentage points in Q3FY22, but also captured higher market share, flying past Air India and SpiceJet, as the new number 2. This development comes ahead of the company’s planned  Rs 3,600-crore IPO. Recent reports suggest that the IPO might be postponed. 

    While the airlines witnessed meaningful recovery in Q3, their happiness is likely to be short-lived owing to the third wave of the pandemic in India. With the fall in leisure as well as business travel, air passenger numbers fell to around 2.4 lakh on January 9, down from 3.85 lakh recorded on December 26. Anticipating a weak Q4, airlines like Indigo have already withdrawn 20% of their capacity in January 2022.

    The rating agency ICRA released another grim statistic for the airline industry recently. The industry is staring at a loss of Rs 25,000-26,000 crore in FY22. Not surprisingly, the CEO of Indigo called the sector “chronically ill” and sought immediate relief from the government. Yet another disappointing quarter lies ahead for investors.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    24 Jan 2022
    Five analyst stock picks this week

    Five analyst stock picks this week

    1. UltraTech Cement: HDFC Securities maintains a ‘Buy’ call on this cement stock with a target price of Rs 8,775 indicating an upside of 19.3%. “We continue to like the company for its strong growth and margin outlook and balance sheet management,” says the analyst Rajesh Ravi. UltraTech Cement’s consolidated EBITDA in Q3FY22 fell 22% to Rs 2,420 crore and profit after tax fell 26% YoY to Rs 1,170 crore, owing to weak demand but the company is hopeful that cost inflation has peaked and noted that the demand was strong post some weakness in November 2021. This should strengthen pricing power and help pass on cost increases to customers. The business is aggressively expanding its green power capacities and working to increase its construction chemicals business, and hence HDFC Securities remains positive on the company.

    2. HCL Technologies: Axis Securities recommends a ‘Buy’ rating for this IT services company with a target price of Rs 1,600, indicating an upside of 37%. The analyst Omkar Tanksale says, “HCL Technologies Q3FY22 performance stood above our expectations and beat our estimate on all fronts.” The company's revenue was up 8.1% QoQ to Rs 22,331 crore while operating profits were up 8.3% QoQ to Rs 5,242 crore. The company’s deal wins continued to remain strong, up 38% YoY. The management gave double-digit revenue growth guidance for FY22 and expects EBIT margins at 19%-21%. According to Axis, the company has built a resilient business model by securing multiple and high-value long-term contracts with the world’s leading brand.

    3. Bajaj Finance: ICICIdirect assigns a ‘Buy’ rating to the financial lender based on the company’s healthy business momentum in Q3FY22 and improved asset quality. The brokerage has a target price of Rs 9,500, indicating an upside of 28.8%. Bajaj Finance posted a strong net interest income growth of 39.7% YoY, beating ICICIdirect’s estimates, says analyst Pankaj Pandey. Asset quality was healthy as GNPA and Net NPA ratios declined 72 bps QoQ to 1.73% and 32 bps to 0.78%,  respectively.  The key ratios are now back to pre-covid levels. According to Pandey, the core business has potential and is well on track to get transformed into an adaptable new age fintech.

    4. Newgen Software Technologies: Edelweiss maintains a ‘Buy’ rating on this software company with a target price of Rs 900 (an upside of 52.2%.) In Q3FY22, the company’s revenue was up 9% QoQ to Rs 202.5 crore and EBITDA margin came in at 29%, up 350 basis points QoQ against 32% expected by Edelweiss. The IT services firm won 17 new deals in mature markets which gives decent revenue visibility. Edelweiss expects strong demand for digital transformation. It also sees the initiatives taken by the company on transition-related initiatives taken by diversifying the sales channel and its pricing model to help it grow. Adding to this the foray into developed markets, will help the company to record a 22% CAGR in revenues, and 24% CAGR in profits over FY 21-24, according to Edelweiss.

    5. ICICI Securities: Motilal Oswal maintains a ‘Buy’ Rating on this brokerage stock, with a target price of Rs 1,000 indicating an upside of 28.5%. “ICICI Securities witnessed flattish retail broking revenue for the seventh consecutive quarter despite improved traction in client acquisitions,” says analyst Prayesh Jain. However, this was more than offset by the strong performance in distribution, Jain adds. The company’s Q3FY22 revenue stood at Rs 940 crore, up by 52% YoY which was 10% higher than Motilal Oswal’s forecasts. Profit after tax rose 42% YoY to Rs 380 crore which was 11% ahead of the brokerage’s estimates. The company saw significant traction in client additions over the past few quarters, driven by digital organic sourcing, strong capital markets, the new tie-up with HDFC Life and new loan product launches. Motilal Oswal expects this momentum to sustain.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    21 Jan 2022
    Five interesting stocks today

    Five interesting stocks today

    • Sterlite Technologies (STL): This optical fibre and wireless solutions-based company’s stock crashed nearly 11% in Thursday’s trading session as investors were surprised by the company’s Q3FY22 results STL clocked losses of nearly Rs 137 crore during the quarter as against a profit of Rs 86.6 crore in Q3FY21. Back in Q2FY22, the company was extremely bullish on the prospects of 5G transition in the telecom industry with reforms and revival and capex cycle underway. Infact, it aimed to clock annual revenues of Rs 10,000 crore by the end of Q4FY23 from around Rs 4,868 crore achieved in FY21, This would have translated to a CAGR of 43%. So what went wrong for this Vedanta Group company? The company charged a one-time provision for losses of Rs 48 crore to its total revenue and Rs 116 crore to its operating expenses which ultimately led to a fall in profits.

    This was done to provide for possible bad debts that can arise from certain ongoing and older projects on its service side of the business. Put simply, the management is anticipating lack of cash collections here. Cash generation was a pertinent issue back in H1FY22 as well with the company reporting an EBITDA of Rs 530 crore and cash flow from operations (before tax) of just Rs 294.5 crore. Notably, the management did not disclose finer details of these old projects nearing their completion in its earnings call. Interestingly, even if we ignore the one-time charge here, the company would still clock a subdued revenue growth of 7% YoY and EBITDA margin of just 10%. In Q2FY22, management gave an EBITDA margin guidance of 16-18% for upcoming quarters. Investors would want to keep an eye on the collection issues this company is facing.

    • Indraprastha Gas: On Wednesday, Indraprastha Gas hit a 52-week low of Rs 450.5 on the bourses. This came after a draft policy note released by the Delhi Government indicated on the minimum requirement of electric vehicles for cab aggregators and delivery services. The company had earlier hiked prices to combat a sharp spike in gas prices.

    This policy would require  that 5% (four-wheelers) and 10% (two-wheelers) of their fleet new purchases are electric vehicles by March 2022. Additionally, 50% of all new two-wheelers and 25% of all new four-wheelers should be electric by March 2023. Interestingly, cab aggregators account for 30-40% of total CNG sales for IGL. Even if this new policy draft was to be approved with certain relaxations, the long-term sales volume growth outlook for the company could alter drastically. Sales volumes may also be impacted in H2FY22 if the price gap between CNG and petrol prices narrows further with IGL hiking prices frequently over the past few weeks. According to Motilal Oswal, two prominent CGDs in China suffered fall in sales growth of 3-11% as EVs gained prominence in the country. Understandably, it is anticipating a flat profit growth trajectory for IGL between FY22-24. The stock could face further pressure in the near term owing to a slowdown in mobility and in road traffic congestion amid the 3rd wave of Covid.

    • Nazara Technologies: This Indian gaming company gained nearly 13.5% in the last one week as it continued on its acquisition spree. The company recently announced  its acquisition of Planet Superheroes and Datawrkz. This is its  continuing effort to build a ‘Friends of Nazara’ network since 2017. It will acquire a 55% stake in Datawrkz for a consideration of nearly Rs 124 crore. The rationale behind this investment is to boost advertising revenues from certain platforms and products like world cricket championship and Sportskeeda. The other key reason is to reduce the user acquisition costs which are more than 20% of Nazara’s revenues.

    Earlier in January, its subsidiary Nodwin Gaming acquired a complete stake in Planet Superheroes for Rs 4.2 crore. The company hopes to effectively engage with a growing Indian gaming community by selling merchandise be it game-based T-shirts, caps, character toys, mugs and lamp shades etc. Planet Superheroes offers its users global merchandise from brands such as Marvel, Disney, Hamleys and Toys R Us. Interestingly, the company also raised the limit for inter-corporate loans to Rs 1,000 crore from Rs 550 crore according to its recent filing. This comes as a red flag for a company which generated net profits of only Rs 28.7 crore on revenues of Rs 533 crore in the last 12 months and a negative cash flow operations of Rs 7 crore in H1FY22. Basically, the previous deals are yet to generate meaningful profit and cash for the company.  Nazara Tech raised Rs 315 crore back in October 2021 from institutional investors. This is after its IPO of Rs 583 crore in March 2021. It will be interesting to see how far these acquisitions go to create durable cash flow generation.

    • Tata Elxsi: This design and technology services company’s stock has been on fire over the past two years rising nearly nine times over the past two years. But in the past two trading sessions, this stock rose over 17%, after it announced its Q3FY22 results touching a new 52-week high on Thursday. This makes it one of the most overbought stocks among the Nifty 500 companies. The company’s profit during the quarter rose nearly 20% QoQ (43.5% YoY), while its revenues were up 6.7% QoQ (33.2% YoY). Trendlyne’s Forecaster consensus average target price is Rs 4,932, while the stock is trading near Rs 7,500 levels. No wonder the consensus recommendation on the stock is to hold on to it.

    • Max Healthcare Institute: This hospital company saw a surge in its promoter group’s pledged shareholding in Q3FY22. This is the first time since Q1FY21 that the company’s promoter shareholding was pledged. The promoter entity Kayak Investments Holding Ptepledged nearly 69% of its stake in the company (69% of 36.40 crore shares or 37.54% stake held by Kayak Investment) held in the company to lenders which include JP Morgan Chase Bank, Nomura Singapore, Deutsche Bank AG, etc. Additionally, the promoter entity also gave an undertaking not to sell its balance unencumbered shareholding, or create any encumbrances contrary to the lending facility agreement signed between. This comes after the promoter entity sold nearly 9.27% stake in two bulk deals on September 29, 2021. Part of this stake sale was picked up by HDFC Mutual Fund, SBI Mutual Fund and Veritas Funds. For now, investors should know that there is no more stake sales coming from Kayak Investments.
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    19 Jan 2022
    Health insurance premiums cushion general insurance companies’ growth

    Health insurance premiums cushion general insurance companies’ growth

    The slump in car and bike sales is leading to a fall in automotive insurance premiums collected by listed insurance players, an analysis of monthly data from regulator IRDA shows. But health insurance premiums rose YoY in October and November 2021, helping insurance companies cushion the blow.

    Although the December 2021 segment data for general insurers is not out yet, October and November 2021 numbers point to an impact of falling auto sales on Bajaj Finserv’s subsidiary Bajaj Allianz General Insurance, ICICI Lombard General Insurance, and The New India Assurance Company. Pure play health insurance player Star Health and Allied Insurance’s 20% YoY premium growth in October-December 2021 shows that the health insurance business continues to grow for the industry as a whole. Bajaj Allianz, ICICI Lombard, and The New India Assurance’s written health insurance premiums rose 26%, 37%, and 19% YoY, respectively in November 2021.

    New India Assurance’s total motor insurance written premiums fell on a YoY basis in October 2021 and November 2021. Similarly, Bajaj Allianz’s motor insurance premiums also fell in those two months. Although ICICI Lombard’s total motor insurance premiums rose marginally in the two months, the own damage insurance premium fell, while third-party insurance premium (legally required for motorists) rose for both months.

    But health insurance written premiums for Bajaj Allianz, ICICI Lombard and New India Assurance rose on a YoY basis in October and December, while Star Health’s rose in all three months of Q3FY22. Essentially, the health insurance premium might save the quarter.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    17 Jan 2022
    Five analyst stock picks this week

    Five analyst stock picks this week

    1. Steel Authority of India (SAIL): Axis Securities initiates coverage on SAIL with a ‘Buy’ recommendation and a target price of Rs 150, implying an upside of 38.95%. SAIL’s modernisation and expansion plan is near completion and the company’s total saleable steel capacity will increase to 20.2 million tonnes per annum post-expansion, according to analyst Aditya Welekar. “We expect steel margins to come under pressure in H2FY22 as lower steel prices will coincide with higher coal price,” Welekar writes. But margins may recover post that as coal prices ease out and steel prices find support with lower demand in China getting balanced by lower production in CY22. Driven by higher profits, Axis Securities expects SAIL to maintain its dividend payout ratio of 28% from FY22 to FY24, which translates into a high dividend yield of 6-8% at current market price. Axis Securities values the company at 4.0x FY24 EBITDA.
    1. Infosys: HDFC Securities maintains a ‘Buy’ rating on Infosys but increased its target price to Rs 2,220 from Rs 1,995 with an upside of 14.10%. Infosys reported robust revenue growth of 7% QoQ and 21.5% YoY in Q3FY22.  Amit Chandra writes, “Its (TCS’) growth trajectory will remain robust supported by a strong deal pipeline and wins, broad-based momentum across verticals, and operational pivots of offshoring and utilization.” These factors will mitigate the near-term impact of higher subcontracting. Chandra remains positive on Infosys and expects 17% EPS CAGR over FY21 to FY24. Chandra is factoring in a YoY dollar revenue growth of 20.1% in FY22, 15.4% in FY23, and 10.5% in FY24. For Q4FY22, the analyst expects 4.1% QoQ growth in dollar revenues.
    1. Tata Consultancy Services (TCS): Motilal Oswal’s analysts Mukul Garg and Raj Bhanushali have a ‘Buy’ rating on TCS with a target price of Rs 4,250, implying an upside of 6.65%. TCS topline grew 16.3% YoY to Rs 48,885 crore in Q3FY22 in a seasonally weaker quarter. The analysts expect this performance to alleviate concerns about its growth potential and the likely drag from the growing share of smaller deals in the market. They also feel IT Services has entered into a technology upcycle, with cloud migration and digital transformation-led deals coming into the market. “Given TCS’ size, capabilities, and portfolio stretch, it is rightly positioned to leverage the anticipated industry growth,” Garg and Bhanushali write. The duo stay positive on TCS factoring in revenue growth of 15% YoY in  FY23.
    1. Gujarat Gas: Prabhudas Lilladhar’s analyst Avishek Datta has a ‘Buy’ rating on Gujarat Gas with a target price of Rs 764,  indicating an upside of nearly 9.42%. “We expect Gujarat Gas’s margins to bottom in Q3 at Rs 2.5 per standard cubic metre and improve in Q4, due to pricing intervention,” Datta writes. Domestic ceramic demand in the residential segment picked up post-pandemic led by home improvements and work-from-home trends. Indian ceramic capacity expanded to 1,320 million square metres in CY20, up 8%YoY, and will likely expand more. Further, a gas price increase of 10-15% is also expected shortly, due to continued high spot prices and any improvement in the geopolitical environment in Ukraine will improve Gujarat Gas profitability. Datta expects a 15.8% CAGR volume growth over FY 23-24.
    1. CRISIL: Monarch Networth Capital gives CRISIL a ‘Buy’ rating with a target price of Rs 3,700,  indicating an upside of 24.92%. “Buoyancy in the capital market will aid strong traction in the domestic research revenues for CRISIL,” Monarch Networth says.  “This, in addition to a seasonally strong quarter for the global benchmarking business, will aid superior earnings growth in the research division.” The brokerage sees traction across segments for the company. CRISIL’s strong parentage, superior margin profile, healthy return ratios - Return on Equity (ROE) at 30% and dividend payout ratio provides comfort. Monarch Networth factors in 15% CAGR growth in CRISIL’s research revenue and a CAGR of 8.5% in its revenue estimate. Monarch Networth also estimates 13% CAGR growth in revenue and 15% growth in earnings over CY 20-23 while expecting ROE to be at 30-31%.
    1
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    17 Jan 2022
    Analysts predict winners and losers of Q3, cement sector sees slowing government spends

    Analysts predict winners and losers of Q3, cement sector sees slowing government spends

    The Q3 earnings season is in full swing, and obviously that is all everyone can talk about (or at least that’s what we want to talk about!) This week’s newsletter looks at analyst consensus estimates to see what could happen in Q3 results. Our Trendlyne Forecaster is here to help.

    In this week’s Analyticks:

    • The cement sector’s foggy winter
    • Upcoming Q3 gainers and losers according to Forecaster’s consensus estimates
    • Screener: Stocks gaining ahead of earnings

    Let’s get into it.


    Cement sector’s near-term outlook softens as government spending slows

    Although top cement companies gave a positive growth outlook for H2FY22, analyst estimates for Q3 earnings results suggest a different story altogether. Interestingly, the average stock returns from the top seven listed cement companies are a meagre 0.1% for the last three months. Brokerages are positive on the cement sector from a medium-term perspective, but investor  interest seems to be waning.

    After posting dismal results in Q2FY22, cement companies like Dalmia Bharat and JK Cement anticipated higher demand in the next two quarters. This expectation was on the back of higher infrastructure spending by the central government. However, the actual capital expenditure numbers published by the Controller General of Accounts are quite lacklustre. 

    The Centre’s capex fell 24% YoY to Rs 23,919 crore in October 2021 and 54% YoY to Rs 20,360 crore in November 2021. If we talk about the year-to-date numbers (April-November 2021), the government managed to spend only 49% of its budgeted capex estimate of Rs 5.54 lakh crore. Accordingly, top brokerages such as ICICI Securities and Axis Securities expect sales volumes of top cement players to fall by an average of 2.4% in Q3FY22. 

    Notably, analysts are not anticipating a major fall in Q3 sales volumes. According to their respective channel checks, volumes did recover in December 2021 as the monsoon season finally receded from India. 

    Another factor is that the price hikes by cement players on cement bags in October 2021 got completely reversed in the following months. According to channel checks by ICICI Securities, the eastern and southern regions of India witnessed the highest price corrections in Q3 due to a fall in demand on delayed withdrawal of the south-west monsoon and a transporters strike. However, the saving grace here is that the pan-India prices are still up by close to 5% YoY at the end of Q3FY22. 

    With a marginal fall in quarterly sales volumes and a sub-par rise in realisations, revenues of cement players are likely to stay flat in Q3FY22 on a YoY basis. 

    The flat trend in quarterly revenues does not bode well for cement players especially when input costs are likely to see a spike on an YoY basis. Analysts expect the cost/tonne metric to rise 14% YoY for the top 13 cement companies led by a jump in fuel prices. As a result, EBITDA/tonne for companies is set to fall nearly 15% YoY on an average. Ramco Cements’ EBITDA/tonne is likely to fall  30% YoY to Rs 1,067 as the company derives roughly 75% of its sales from the southern region. 

    Prabhudas Lilladher sees a 520 bps fall in EBITDA margins of market leader UltraTech Cement. A possible reason could be a large exposure (36% share in sales) to the eastern and southern regions. Although Dalmia Bharat derives 60% of its topline from the eastern region, brokerages have a divergent view on its likely operating performance. Axis Securities expects a 130 bps erosion in its EBITDA margins while HDFC Securities sees a 440 bps fall in its margins. 

    As a consequence of flat revenues and lower margins led by high input costs, net profit of the top players is set to decline in double digits for Q3FY22. Interestingly, ACC is set to report a 17% YoY rise in its Q3 net profits based on the bullish view of HDFC Securities.

    While investors are in for yet another disappointing quarter, power and fuel costs for cement players are likely to normalize in Q4FY22. International coal and pet coke prices fell from their all-time highs in November first week. This provides some breather to companies. According to IIFL Securities, cement dealers are hopeful of a demand revival in January 2022 as the peak construction season kicks in. However, the rapid spread of omicron may put brakes on the Centre’s capex plans and may snap the chances of a meaningful recovery in cement demand. All in all, the outlook for the cement sector in H2FY22 looks quite blurry this winter.


    Forecaster Consensus: Slowing sales may dent Maruti’s Q3FY22 profit, Dr Reddy’s may shine

    The big boys—Tata Consultancy Services,Infosys, and Wipro—were the first ones among the Nifty 50 to announce their Q3FY22 earnings on Wednesday. Wipro’s earnings per share for Q3FY22 was largely flat at Rs 5.43 per share, but missed Trendlyne’s Forecaster’s average consensus estimate (Rs 5.40 per share). Wage hikes and high attrition dented the company’s margins which came in at 17.6%.

    Although TCS’ Q3FY22 EPS of Rs 26.4 per share was marginally below the average consensus estimate (Rs 26.9 per share), the company’s stellar growth in revenues helped IT bellwether cross $25 billion in revenues in 2021.

    The standout performer till now is Infosys which posted stellar earnings with an EPS of Rs 13.9 per share, which is above the consensus estimate of Rs 13.4 per share. The company’s Q3 performance led the management to upgrade its revenue guidance to 19.5%-20% in FY22, up from 16.5%-17.5%.

    Now that the earnings season is in full flow, we decided to look at Trendlyne Forecaster’s average of consensus estimates to find out the top five companies that analysts expect to post good and bad earnings in Q3FY22.

    Dr Reddy’s Q3FY22 profits may get a base effect boost

    In Q3FY21, Dr Reddy’s Laboratories suffered an impairment loss on inventory and other intangible assets to the tune of nearly Rs 600 crore led to a fall in its net profit. This resulted in its standalone EPS coming in at around Rs 1.70 per share. This low base, in case there is no recurring impairment charge, may see the company post a rise in its earnings in Q3FY22.

    The average consensus estimate expects Bajaj Finance to post stellar earnings in Q3FY22. According to Trendlyne Forecaster’s estimate, the company’s EPS may more than double during the quarter. This may happen on the back of a 26.3% rise in the company’s assets under management to Rs 1,81,300 crore in Q3.

    Maruti’s slowing wholesale dispatches and retail sales expected to bite in Q3FY22

    The auto industry is reeling under supply-chain issues, and high fuel costs aren’t helping the sector’s cause either. Market leader in the Indian passenger vehicle market—Maruti Suzuki had to resort to multiple production cuts as it curbed dispatches to dealers during Q3FY22. The company’s wholesale dispatches to dealers and exports fell 13.2% YoY to 4,30,668 units during the quarter. This is despite the company’s retail sales picking up in Q3 from October onwards after falling for three consecutive months. This is bound to dent the company’s EPS in Q3.

    Similarly, Hero MotoCorp and Bajaj Auto may also see a dent in their Q3 earnings. It’s not surprising that the top five companies that may see the highest fall in EPS (according to Trendlyne Forecaster’s estimates) are from the automotive industry. The one-two punch of poor rural demand and supply chain issues is bearing heavily on the sector’s prospects.


    Screener: Stocks swinging ahead of their Q3FY22 results

    With another earnings season underway, investors will be hoping the hype priced into stocks pays off. The third wave has not yet played spoilsport, with the benchmark Nifty 50 hovering above 18,000 levels. The earnings announcements will be the next trigger for many companies, but some stocks are trading higher ahead of results being announced.

    This screener shows there are 53 companies among the Nifty 500 as of Wednesday that saw a weekly rise in their share price ahead of their results being announced. Some companies like Asian Paints and Tanla Platforms touched their 52-week high ahead of their Q3FY22 results. This suggests that investors hoping for a bite of the cherry before the stock potentially surges post results. This screener also shows the 1-year high price along with its current market price.

    Financial services companies like ICICI Bank, HDFC Bank, Bajaj Finance, Cholamandalam Investment & Finance Company, Housing Development Finance Corporation, and Axis Bank are gaining momentum. HDFC Bank and Bajaj Finance recently announced their operational update for Q3FY22 which showed decent growth in business.

    Other companies’ shares that are rising are from the paints, specialty chemicals, IT services, and pharmaceuticals industries, including Kansai Nerolac, HCL Technologies, GlaxoSmithKline Pharmaceuticals, Atul and BASF India. IT stocks have been on a high since the second week of December 2021. A news report suggests that IT companies generally have a slow season in Q3FY22, but this financial year could be an exception as Covid related lockdowns and restrictions have led to a rise in demand for digital transformation spending for even mid-cap companies.

    You can find more expert screeners here.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    14 Jan 2022
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    • Tata Steel: This steel company’s stock yielded negative returns in the past three months, along with most other steel stocks This correction in steel stocks comes after a 11% fall in domestic hard-rolled coil prices ever since November, 2021. Although ICICI Securities maintains a ‘Buy’ rating on Tata Steel, it reduced its target price by 15% in December 2021.

    On Tuesday, Jefferies India downgraded the steel sector, and hence Tata Steel, to ‘Sell’. Jefferies believes muted real estate demand from the Chinese market and softening steel prices will likely impact Tata Steel’s margins from H2FY22 onwards. It expects EBITDA margins to contract in FY23 as spot steel prices may fall further by 9-10%. This may lead to a 44% fall in earnings. Interestingly, Indian brokerages like Axis Direct and Prabhudas Lilladher still hold a positive view on the steel sector. They anticipate that steel prices will not fall materially in FY23 as lower demand in China might be balanced out by lower production. Only time will tell whether the commodity cycle actually turns for the worse in FY23.

    • Hinduja Global Solutions: The journey of this stock in 2022 is nothing short of a theatrical drama. It hit a 52-week high on January 4, 2022 in anticipation of a dividend declaration and bonus issue. However, on January 7, the stock plunged nearly 20% after the company announced a special dividend of Rs 150 per share and a bonus issue of 1:1. An anticlimax you would think? Well, not exactly.

    The company had earlier faced investors’ ire when it extended short-term loans of Rs 340 crore to its group entities in Q4FY20. HGS’ management informed them of this development only in August 2020 when the loan was already paid off. The company got embroiled in yet another corporate governance issue as it concluded the sale of its flagship healthcare services division. The cash inflow for the company in this deal is around Rs 8,082 crore while dividend outgo is a meagre Rs 315 crore. However, investors have a much bigger concern here. They suspect that a major part of this inflow will go to the related parties. This belief is backed by the company's history and the fact that the board raised the limit for corporate loans to Rs 3,500 crore from just Rs 500 crore. Also, as the company hives off the healthcare division, its earnings could fall by nearly 30-40% taking down the stock price as well. This story is far from over as the company recently announced that it will consider a buyback proposal on January 14. Only time will tell whether this move is a pure gimmick to support stock prices or real value lies on the table for the investors.

    • Avenue Supermarts (DMart): This stock slumped during intraday trade on Wednesday because of the company’s Q3FY22 earnings being a mixed bag. The company’s consolidated net profit rose 23.4% YoY to Rs 5,526 on a  22.2% YoY rise  in revenues to Rs 9,220 crore. However, gross margins remained flat at 15.4% YoY because of lower sales of general merchandise and apparel. Brokerage Prabhudas Lilladher suggests that a deterioration in sales mix and an expected rise in expenses by 15.2% YoY might hamper margins going forward. The brokerage has a  ‘Hold’ rating on the stock as it expects store expansions and increasing share of essentials in the sales mix to drive profit growth at a 31% CAGR from  FY20-24.

    On the other hand, ICICI Securities downgraded its target price for Avenue Supermarts expecting footfalls to decrease and demand for general merchandise and apparel to stall in H2FY22. ICICI Securities feels  the trend of tepid demand is likely to continue due high inflation and reduced mobility because of restrictions on movement of people due to the pandemic’s third wave in many cities the company operates in.

    • Abbott India: This stock rallied for five continuous sessions in the last week of December 2021 and ended up 5.8%, but since January 1, the stock is on a downward trajectory losing nearly 8.5% . A recent report from Axis Securities says that the company’s Q2FY22 performance has been robust and its average growth rate of 11% in October 2021 and November 2021 outpaces the Indian Pharma Market’s growth of 5.8% by 520 bps. Axisreduced its target price by 2.7% to Rs 20,000 as it believes that the stock has limited upside. However, the brokerage maintains a positive outlook on the company and has a ‘Buy’ rating on the stock. According to Axis Securities’ report, the company retains its leading position in segments like women’s health, gastroenterology, metabolic, pain management, CNS, and vaccines. Axis Securities believes that its branded business will improve the company’s profitability in H2FY22. The distinct factor for this company’s growth prospects is its strategy of going digital and providing services beyond just medicinal pills and venturing into diagnostics, medical devices, and nutrition.

    • Affle India: This advertising technology company’s stock is on fire. Till date in 2022, it is up nearly 27% and has been touching new highs regularly. It’s the most overbought stock among the Nifty 500 companies, according to technical indicators like RSI and MFI. During this upward movement of the company’s stock, existing investor Malabar India Fund sold 1,05,739 shares in a bulk deal to Value Partners High-Dividend Stocks Fund. The stock is currently trading above all its simple moving averages.
    1
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    11 Jan 2022, 03:00PM
    Omicron restrictions may hit car sales more than chip shortages

    Omicron restrictions may hit car sales more than chip shortages

    Passenger vehicle makers have been reeling under the impact of semiconductor shortages in FY22. Lockdown restrictions imposed by state governments in April-June 2021 hit retail sales, but there was a recovery from July 2021 as pent-up demand from customers drove sales at dealers. Demand also recovered with new launches. 

    Another major concern however was the long wait times for new vehicles due to supply-side constraints for carmakers. Still, Q2FY22 saw retail sales of passenger vehicle sales reach pre-Covid levels.Mahindra & Mahindra’s retail sales were helped by the launch of its XUV700 with its aggressive new design. It became the vehicle with the longest waiting period, and received more than 1.6 lakh bookings in Q2FY22. With one more launch lined up in FY22, the company is hoping for more of the same.

    Maruti Suzuki’s strong brand presence and distribution network led to an increase in retail sales in Q3FY22. Except for a brief period in September 2021 and October 2021, sales were on a rising trend.Tata Motors retail sales are rising after a lull in Q2FY22. This is despite its wholesales rising 56.3% YoY to 1.7 lakh units in Q2FY22.

    Mahindra & Mahindra’s wholesales dipped to 17,722 units in December 2021 from 19,458 units a year ago, which dovetails with a marginal rise in retail sales over the month. It will be interesting to see if wholesale dispatches to dealers continue to translate into retail sales at a fair clip as the third wave might lead to curbs on discretionary expenditure. The elevated fuel prices and supply-side issues may also impact demand for cars in Q4FY22.

    2
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    10 Jan 2022
    Five analyst stock picks this week

    Five analyst stock picks this week

    1. Aptus Value Housing Finance India: LKP Securities gives a ‘Buy’ rating to Aptus Value Housing Finance India (Aptus) with a target price of Rs 477 - a potential upside of 33.58%. LKP Securities says Aptus consistently delivered a return on assets (ROA) of more than 6% since FY16. It also has a high capital base and lower leverage, which keeps the return on equity (ROE) above 12%. LKP Securities estimates an ROA and ROE of 7% and 15%, respectively, for FY22. The company’s collection efficiency improved to pre-Covid levels and stood at 99.7% in the quarter ended September 2021 compared to 95% for the quarter ended  June 2021. The collection efficiency remained robust despite the pandemic, and asset quality was steady. “A lower stress is likely to keep the credit cost in check, which may translate into better profitability in coming years,” says LKP Securities. LKP Securities expects strong growth in assets under management, stable net interest margin of 10.6%, and operating expense ratio or opex of 2.2% to help to deliver strong profit growth of 27% CAGR over FY21-FY24.

    1. Coforge: Based on record deals won by this company, Axis Securities maintained its ‘Buy’ rating on Coforge with a target price of Rs 6,870 and an upside of 21.22%. Coforge bagged deals worth $781 million in FY21, a growth of 11% YoY. Revenue growth in FY21 stood at 11.4% with operating margins at 18%, an expansion of 80 basis points over the previous year. Margin expansion was aided by higher offshoring, higher utilization, lower attrition, and a favorable currency mix during FY21. Due to the pandemic, Coforge witnessed a robust digital demand wave, and this is expected to continue. Coforge also continues to invest in human capital to build strong capabilities to fulfill client requirements. Axis Securities believes the company is likely to have better revenue growth and operating margin expansion prospects in the near future as the management has guided for double-digit growth in FY22 by factoring in robust deal wins in the recent past.

    1. Coal India:  ICICI Securities gives a ‘Buy’ rating to Coal India (CIL) with a target price of Rs 234 and an upside of 47.36%. CIL recorded an all-time high production during the nine months ended FY22 at 413.6 million tonnes. Key factors behind the surge in production volumes are higher power demand, low coal stocks at most power plants, unprecedented power prices on exchanges in October 2021, and global elevated coal prices. Coal prices are expected to rise again as Indonesia bans exports amid increasing demand for coal. Further, demand for coal is higher in most major coal importing countries. “This is likely to make CIL a preferred coal supplier for domestic consumers in the medium term as it remains at a 50% discount to international prices,” says ICICI Securities, which expects a good dividend payout from CIL in FY22. 

    1. KPR Mill: Analysts at Edelweiss Wealth Research are enthused at  KRP Mill’s prospects based on two themes – fashion and its ethanol business. It has a ‘Buy’ rating on the stock with a target price of Rs 860, with an upside of 18.78%. The garment segment has provided a steady balance to the company’s growth, as this grew at a CAGR of 16% over the past nine years. Due to government policies that boosted demand for ethanol, the company increased its ethanol capacity to 130 kilo litres per day (KLPD), which will be enhanced to 360 KLPD by Q4FY22. Edelweiss Wealth Research forecasts that the sugar/ethanol segment will generate revenue of Rs 1,400 crore by FY24. It also expects KPR Mill’s EBITDA  to grow at a 24% CAGR translating into a margin expansion of 340bps. This could translate into a net profit growth of  29% CAGR with healthy return on capital employed (ROCE) of 28%and RoE of 25% by FY24.

    1. SBI Cards and Payment Services: HDFC Securities initiates coverage on SBI Cards and Payment Services with a ‘Buy’ rating and a target price of Rs 1,100 with an upside of 21.4%. SBI Cards and Payment has emerged as a formidable, high-quality, high-growth franchise that is poised for sustained earnings growth of 45% EPS CAGR and high profitability of RoA of 5.2% over FY21-FY24, says the analysts. SBI Cards’ strategy of maintaining a balanced mix of Open Market and Banca customers “bodes well for superior profitability and credit risk management”. HDFC Securities expects SBI Cards to deliver 6.2%  RoE and 28% RoA by FY24 led by strong growth in CIF/spends and steady unit economics.
    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd